Penumbra

PEN NYSE
139.74
-5.18
-3.57%
After Hours: 140.96 +1.22 +0.87% 16:11 08/23 EDT
Open
144.55
Prev Close
144.92
High
145.30
Low
139.14
Volume
262.16K
Avg Vol (3M)
377.57K
52 Week High
185.70
52 Week Low
110.84
% Turnover
0.75%
Market Cap
4.86B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Penumbra PEN stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Penumbra, Inc. is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address include ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. It focuses on developing, manufacturing and marketing products for use by specialist physicians, including interventional neuroradiologists, neurosurgeons, interventional neurologists, interventional radiologists and vascular surgeons. Its neuro products include Neurovascular Access, Neuro Thrombectomy (Ischemic Stroke), Neurovascular Embolization (Brain Aneurysms) and Neurosurgical Tools (Hemorrhagic Stroke). Its peripheral vascular products include Peripheral Vascular Embolization and Peripheral Thrombectomy.
MORE >

Recently

Name
Price
%Change